Reassessing the Management of Treatment-Induced Brain Necrosis in Metastatic Patients: Advancing Surgical Alternatives to Steroid Therapy

The emergence of modern adjuvant therapies has significantly improved outcomes for patients with brain metastases. However, treatment-related side effects present an ongoing challenge, particularly, treatment-induced necrosis characterized by perilesional edema and inflammation. Standard management with steroids compromises the efficacy of otherwise efficacious immunotherapeutic approaches. This position paper critiques traditional management strategies that rely heavily on systemic corticosteroid therapy-often ineffective in providing lasting relief and associated with serious side effects-and proposes a paradigm shift that prioritizes surgical resection. Resection facilitates prompt edema reduction with a low recurrence rate of symptoms and mitigates the adverse effects of prolonged corticosteroid use. We propose increased consideration for resecting symptomatic radiation necrosis to facilitate improved efficacy of immunotherapies in patients with brain metastases.

Authors

Institutions

Publication Details

Journal
Neurosurgery Open
Published
2025-10-28
DOI
https://doi.org/10.1227/neuprac.0000000000000185
Primary Topic
Brain Metastases and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Reassessing the Management of Treatment-Induced Brain Necrosis in Metastatic Patients: Advancing Surgical Alternatives to Steroid Therapy

Joshua D. Bernstock, Nicholas B. Dadario, Pierpaolo Peruzzi, Jakob V. E. Gerstl et al.
Neurosurgery Open
Brain Metastases and Treatment
article

Reassessing the Management of Treatment-Induced Brain Necrosis in Metastatic Patients: Advancing Surgical Alternatives to Steroid Therapy

Joshua D. Bernstock, Nicholas B. Dadario, Pierpaolo Peruzzi, Jakob V. E. Gerstl, Timothy R. Smith, Pablo A. Valdés, Omar Arnaout, Wenya Linda Bi, Ayal A. Aizer, Lennard Spanehl, E. Antonio Chiocca, Florian Geßler, Benjamin R. Johnston, Gregory K. Friedman
article en

Abstract

The emergence of modern adjuvant therapies has significantly improved outcomes for patients with brain metastases. However, treatment-related side effects present an ongoing challenge, particularly, treatment-induced necrosis characterized by perilesional edema and inflammation. Standard management with steroids compromises the efficacy of otherwise efficacious immunotherapeutic approaches. This position paper critiques traditional management strategies that rely heavily on systemic corticosteroid therapy-often ineffective in providing lasting relief and associated with serious side effects-and proposes a paradigm shift that prioritizes surgical resection. Resection facilitates prompt edema reduction with a low recurrence rate of symptoms and mitigates the adverse effects of prolonged corticosteroid use. We propose increased consideration for resecting symptomatic radiation necrosis to facilitate improved efficacy of immunotherapies in patients with brain metastases.

Neurosurgery OpenVol. 6(4)
Brigham and Women's Hospital (US), Boston Children's Hospital (US), The University of Texas MD Anderson Cancer Center (US), Harvard University (US), Dana-Farber Cancer Institute (US), Dana-Farber Brigham Cancer Center (US), University of Rostock (DE), Massachusetts Institute of Technology (US), Webster University (US)
Openalex Percentile: Top 52%
Brain Metastases and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.